Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vadastuximab talirine plus hypomethylating agents: A well-tolerated regimen with high remission rate in frontline older patients with acute myeloid leukemia (AML)
    Meeting Abstract

    Fathi, A. T.; Erba, H. P.; Lancet, J. E.; Stein, E. M.; Ravandi, F.; Faderl, S.; Walter, R. B.; Advani, A.; DeAngelo, D. J.; Kovacsovics, T. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Importance of achieving complete remission (CR) after intensive therapy for acute myeloid leukemia (AML) in older adults age >= 60 years: Analysis of risk factors for early mortality and re-induction, and impact of quality of response on overall survival (OS) in the ECOG-ACRIN E2906 randomized trial
    Meeting Abstract

    Foran, J. M.; Sun, Z.; Claxton, D. F.; Lazarus, H. M.; Thomas, M. L.; Melnick, A.; Levine, R. L.; Paietta, E.; Arber, D. A.; Zhang, Y.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Cooperative gene repression by DNA methylation and LSD1-mediated enhancer inactivation in acute myeloid leukemia
    Meeting Abstract

    Duy, C.; Teater, M.; Garrett-Bakelman, F. E.; Lee, T. C.; Meydan, C.; Glass, J. L.; Li, M.; Mohammad, H.; Smitheman, K.; Shih, A. H.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Mutational analysis of clonal hematopoiesis in solid tumor patients illustrates the critical role of systemic anti-cancer therapies in the evolution of somatic leukemia disease alleles
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; Arcila, M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Determination of IDH1 mutational burden and clearance via next-generation sequencing in patients with IDH1 mutation-positive hematologic malignancies receiving AG-120, a first-in-class inhibitor of mutant IDH1
    Meeting Abstract

    DiNardo, C. D.; de Botton, S.; Stein, E. M.; Roboz, G. J.; Swords, R. T.; Pollyea, D. A.; Fathi, A. T.; Collins, R.; Altman, J. K.; Flinn, I. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • An analysis of the transcriptional response of myelodysplastic syndrome stem cells to therapy at single cell resolution
    Meeting Abstract

    Chung, S. S.; Vijay, P.; Stern, D. L.; Klimek, V. M.; Mason, C. E.; Park, C. Y.
    Blood (2016)

    Fulltext@MSK | Save
  • An epigenetic regulator screen identifies novel targets that sensitize MLL-rearranged leukemia to DOT1L inhibition
    Meeting Abstract

    Chen, C. W. D.; Delaney, C.; Xu, H.; Koche, R.; Goizueta, A. L.; Hoshii, T.; Cusan, M.; Chabon, J.; Valerio, D. G.; Kuehn, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • H3B-8800, an orally bioavailable modulator of the SF3b complex, shows efficacy in spliceosome-mutant myeloid malignancies
    Meeting Abstract

    Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Caleb, B.; Darman, R.; Fekkes, P.; Karr, C.; Keaney, G. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • IL-18 secreting CAR T cells enhance cell persistence, induce prolonged B cell aplasia and eradicate CD19+ tumor cells without need for prior conditioning
    Meeting Abstract

    Avanzi, M. P.; van Leeuwen, D. G.; Li, X.; Cheung, K.; Park, H.; Purdon, T. J.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Vadastuximab talirine monotherapy in older patients with treatment naive CD33-positive acute myeloid leukemia (AML)
    Meeting Abstract

    Bixby, D. L.; Stein, A. S.; Fathi, A. T.; Kovacsovics, T. J.; Levy, M. Y.; Erba, H. P.; Lancet, J. E.; Jillella, A. P.; Ravandi, F.; Walter, R. B.; more...
    Blood (2016)

    Fulltext@MSK | Save